Search Results
| No. |
VISDB ID▲▼ |
Virus Name▲▼ |
Subtype▲▼ |
Virus Genome▲▼ |
Breakpoint 1▲▼ |
Breakpoint 2▲▼ |
Human Genome▲▼ |
Chr▲▼ |
Start▲▼ |
End▲▼ |
Loci▲▼ |
Target Gene▲▼ |
Sample Type▲▼ |
Disease▲▼ |
Method▲▼ |
PubMed ID▲▼ |
Year▲▼ |
Curated Way▲▼ |
| 8251 |
TVIS20025113
|
Human Papillomavirus |
HPV33 |
M12732 |
4411 |
- |
hg38 |
chr10 |
42819139 |
42819139 |
q11.21 |
BMS1 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 8252 |
TVIS20025114
|
Human Papillomavirus |
HPV33 |
M12732 |
548 |
- |
hg38 |
chr16 |
3429726 |
3429726 |
p13.3 |
ENSG00000285329 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 8253 |
TVIS20025115
|
Human Papillomavirus |
HPV33 |
M12732 |
6332 |
- |
hg38 |
chr20 |
767371 |
767371 |
p13 |
SLC52A3 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 8254 |
TVIS20025116
|
Human Papillomavirus |
HPV33 |
M12732 |
235 |
- |
hg38 |
chr9 |
78335977 |
78335977 |
q21.2 |
- |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 8255 |
TVIS20025117
|
Human Papillomavirus |
HPV33 |
M12732 |
3492 |
- |
hg38 |
chr10 |
30527607 |
30527607 |
p11.23 |
- |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 8256 |
TVIS20025118
|
Human Papillomavirus |
HPV33 |
M12732 |
1124 |
- |
hg38 |
chr5 |
148944836 |
148944836 |
q32 |
SH3TC2 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 8257 |
TVIS20025119
|
Human Papillomavirus |
HPV16 |
K02718 |
7266 |
- |
hg38 |
chr3 |
60594701 |
60594701 |
p14.2 |
FHIT |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 8258 |
TVIS20025120
|
Human Papillomavirus |
HPV16 |
K02718 |
858 |
- |
hg38 |
chr3 |
60594676 |
60594676 |
p14.2 |
FHIT |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 8259 |
TVIS20025121
|
Human Papillomavirus |
HPV16 |
K02718 |
7554 |
- |
hg38 |
chr5 |
24515286 |
24515286 |
p14.2 |
CDH10 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 8260 |
TVIS20025122
|
Human Papillomavirus |
HPV16 |
K02718 |
1306 |
- |
hg38 |
chr1 |
33989354 |
33989354 |
p35.1 |
ENSG00000295180, CSMD2 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |